Jingjing Li

Bio: Jingjing Li is an academic researcher from University of California, San Francisco. The author has an hindex of 1, co-authored 1 publications receiving 1 citations.

Missing Teeth and Restoration Detection Using Dental Panoramic Radiography Based on Transfer Learning With CNNs

Abstract: Common dental diseases include caries, periodontitis, missing teeth and restorations. Dentists still use manual methods to judge and label lesions which is very time-consuming and highly repetitive. This research proposal uses artificial intelligence combined with image judgment technology for an improved efficiency on the process. In terms of cropping technology in images, the proposed study uses histogram equalization combined with flat-field correction for pixel value assignment. The details of the bone structure improves the resolution of the high-noise coverage. Thus, using the polynomial function connects all the interstitial strands by the strips to form a smooth curve. The curve solves the problem where the original cropping technology could not recognize a single tooth in some images. The accuracy has been improved by around 4% through the proposed cropping technique. For the convolutional neural network (CNN) technology, the lesion area analysis model is trained to judge the restoration and missing teeth of the clinical panorama (PANO) to achieve the purpose of developing an automatic diagnosis as a precision medical technology. In the current 3 commonly used neural networks namely AlexNet, GoogLeNet, and SqueezeNet, the experimental results show that the accuracy of the proposed GoogLeNet model for restoration and SqueezeNet model for missing teeth reached 97.10% and 99.90%, respectively. This research has passed the Research Institution Review Board (IRB) with application number 202002030B0.

Realm of proteomics in breast cancer management and drug repurposing to alleviate intricacies of treatment.

Abstract: Breast cancer, a multi-networking heterogeneous disease, has emerged as a serious impediment to progress in clinical oncology. Although technological advancements and emerging cancer research studies have mitigated breast cancer lethality, a precision cancer-oriented solution has not been achieved. Thus, this review will persuade the acquiescence of proteomics-based diagnostic and therapeutic options in breast cancer management. Recently, the evidence of breast cancer health surveillance through imaging proteomics, single-cell proteomics, interactomics, and post-translational modification (PTM) tracking, to construct proteome maps and proteotyping for stage-specific and sample-specific cancer subtyping have outperformed conventional ways of dealing with breast cancer by increasing diagnostic efficiency, prognostic value, and predictive response. Additionally, the paradigm shift in applied proteomics for designing a chemotherapy regimen to identify novel drug targets with minor adverse effects has been elaborated. Finally, the potential of proteomics in alleviating the occurrence of chemoresistance and enhancing reprofiled drugs' effectiveness to combat therapeutic obstacles has been discussed. Owing to the enormous potential of proteomics techniques, the clinical recognition of proteomics in breast cancer management can be achievable and therapeutic intricacies can be surmountable.